Line 45: |
Line 45: |
| * Only MHC class I that is associated with peptide will be expressed at the surface. | | * Only MHC class I that is associated with peptide will be expressed at the surface. |
| ** The immune system is therefore able to see antigen from intracleeular pathogens. | | ** The immune system is therefore able to see antigen from intracleeular pathogens. |
| + | |
| + | |
| + | ==Structure and Function Of MHC Class II== |
| + | |
| + | ===Structure=== |
| + | |
| + | * MHC class II is expressed mainly on macrophages, dendritic cells and B-lymphocytes. |
| + | * MHC class II consists of membrane-associated α and β chains. |
| + | ** Each chain is a transmembrane glycoprotein. |
| + | ** The extracellular parts of each chain have two Ig-like domains. |
| + | *** α1 and 7alpha;2, β1 and β2. |
| + | **** The outer domains (α1 and β1) are variable-like. |
| + | **** The inner domains (α2 and β2) are constant-like. |
| + | * The 3-dimensional structure of MHC class II is similar to MHC class I. |
| + | ** The outer domains of the α and β chains fold in a similar way to the α1 and α2 domains of class I. |
| + | *** Produce the antigen-binding groove. |
| + | |
| + | ===Function=== |
| + | |
| + | * MHC class II molecules bind antigenic peptides and present them to TcR on CD4+ T-cells. |
| + | * The antigen-binding groove is larger and more open than that of MHC class I. |
| + | ** MHC II can therefore interact with larger peptides. |
| + | * MHC class II are present on those cells that have antigen-processing ability. |
| + | ** Interact with antigenic peptides originating from an extracellular source. |
| + | * After synthesis, MHC class II molecules are transported into special endosomes. |
| + | ** These endosomes fuse with lysosomes that contain the digested remnants of phagocytosed microorganisms. |
| + | *** The peptides from the lysosome interact with the MHC class II molecules. |
| + | **** The peptide-MHC class II complex gets transported to the cell surface. |
| + | |
| + | ==Interaction of MHC With Antigen== |
| + | |
| + | * The MHC molecules do not recognise specific amino acid sequences of antigens. |
| + | ** Instead, they recognise particular motifs of amino acids. |
| + | * The association of any MHC allele with a peptide may be determined by the presence of as few as two amino acids. |
| + | ** However, these determinants must be present within a particular array. |
| + | * The actual identity of the amino acids in not important for MHC binding. |
| + | ** Instead, the physical and chemical characteristics of the amino acid are vital. |
| + | * Interactions of individual amino acids at the head and tail of the peptide-binding groove control the binding of peptides. |
| + | ** Are mainly positioned at the floor of the antigen-binding groove, or within the helices facing into the groove. |
| + | ** These MHC amino acids associate with amino acids near the ends of the peptides. |
| + | *** The intervening stretch of peptide folds into a helix within the groove. |
| + | *** Is the target for T cell receptor recognition. |
| + | |
| + | ===TcR-MHC Interaction=== |
| + | |
| + | * Only peptide associated with self-MHC will interact with and activate T-cells. |
| + | ** T-cells cannot be activated by a peptide on a foreign cell. |
| + | ** T-cells will react against foreign MHC molecules. |
| + | *** This is the basis of graft rejection. |
| + | |
| + | ===The Genetics of the MHC=== |
| + | |
| + | * Different individuals have different critical amino acids within the MHC. |
| + | ** I.e. different amino acids that determine peptide binding. |
| + | ** This variation is termed '''MHC polymorphism'''. |
| + | * There are millions of variations in antibodies and TcR. |
| + | ** However, with MHC there is very limited variation between molecules. |
| + | * MHC polymorphism has been best studied in the human. |
| + | |
| + | ===In the Human=== |
| + | |
| + | * Humans express: |
| + | ** Three types (loci) of MHC class I molecules. |
| + | *** HLA (Human Leukocyte Antigen)- A, B, and C. |
| + | ** Three loci of MHC class II molecules. |
| + | *** HLA-DP, DQ and DR. |
| + | * In the entire human population there are only approximately 50 different variants (alleles) at each MHC class I and class II locus. |
| + | ** The variation within MHC class I is entirely on the class I heavy chain. |
| + | *** The β2m is invariant. |
| + | ** The variation within MHC class II is mainly within the β chains. |
| + | * Every individual has two alleles at each MHC locus. |
| + | ** One inherited from each parent. |
| + | ** Any individual will therfore express two variants at most at each locus. |
| + | *** This gives a maximum variability for an individual of: |
| + | **** 6 different variants of MHC class I. |
| + | ***** 2 each of HLA- A, B and C. |
| + | **** 6 different variants of MHC class II. |
| + | ***** 2 each of HLA- DP, DQ and DR. |
| + | * Many animal species have fewer loci than the human. |
| + | ** E.g. ruminants have no MHC class II DP. |
| + | |
| + | ===MHC and Disease=== |
| + | |
| + | * Antigen from a pathogen has to be seen by the host MHC before an efficient immune response can occur. |
| + | ** There is therefore a constant evolutionary battle between the host and the pathogen. |
| + | *** There is selective pressure on the pathogen to evolve proteins that do not interact with the host MHC. |
| + | *** There is selective pressure on the host to continue to recognize the pathogen. |
| + | * The consequence of this parallel evolution is that host-pathogen relationships can lead to the selection of particular MHC variants, for example: |
| + | ** MHC class II alleles DR13/DR1*1301 are prevalent in Central and Western Africa . |
| + | *** Impart resistance to malaria. |
| + | ** MHC-DRB1 is prevalent in Western Europe, but rare in the Inuit populations of North America. |
| + | *** Associated with the clearance of hepatitis B infection in Western Europe. |
| + | *** Inuits have the highest incidence of hepatitis B in the world. |
| + | ** In humans there are also strong associations between certain alleles and some autoimmune diseases, for example: |
| + | *** Diabetes mellitus. |
| + | *** Ankylosing spondylitis. |
| + | *** Rheumatoid arthritis. |